Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.
J Clin Virol
; 58(1): 303-5, 2013 Sep.
Article
en En
| MEDLINE
| ID: mdl-23890809
Palabras clave
APHL; Ab; Ag; Algorithm; Association of Public Health Laboratories; CDC; CE; CLSI; Centers for Disease Control and Prevention; Clinical and Laboratory Standards Institute; DNA; EIA; European conformity; FDA; Food and Drug Administration; GS; Guideline; HIV; INNO-LIA HIV I/II score; Ind; Inno-LIA; LSR; M53; N/T; NLHRS; National Laboratory for HIV Reference Services; New tests; PCR; Pos; RIPA; RNA; WB; Western blot; antibody; antigen; deoxyribonucleic acid; enzyme immunoassay; genetic systems; human immunodeficiency virus; indeterminate; lab-specific report; not tested; polymerase chain reaction; positive; radioimmunoprecipitation assay; ribonucleic acid
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Virología
/
Infecciones por VIH
/
VIH-1
/
VIH-2
/
Técnicas de Laboratorio Clínico
/
Ensayos de Aptitud de Laboratorios
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Clin Virol
Asunto de la revista:
VIROLOGIA
Año:
2013
Tipo del documento:
Article
Pais de publicación:
Países Bajos